MG
Melanie Greenland
University of Oxford, The University of Western Australia, University of Reading, University of Birmingham, PRA Health Sciences Reading
Research areas: Medicine · Infectious Diseases · SARS-CoV-2 and COVID-19 Research · Vaccine Coverage and Hesitancy · Pregnancy and preeclampsia studies
0000-0001-9363-8844
Employment
-
University of Oxford Medical Statistician2020 - Present
-
University of Oxford Medical Statistician2019 - 2020
-
University of Western Australia Research Associate2017 - 2019
-
University of Oxford Medical Statistician2015 - 2017
-
PRA Health Sciences Reading Biostatistician2014 - 2015
Education
-
University of Reading MSc Biometry? - 2014
-
University of Birmingham BSc Mathematics? - 2013
Projects & Funding
-
Understanding associations between reactogenicity, immunogenicity and genetics following vaccination NIHR Academy2025 - 2028
Publications (43)
- SARS-CoV-2-Specific Immune Responses to Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study Save
- MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines Save
- SARS-CoV-2-Specific Immune Responses to COVID-19 Vaccination in Children and Adolescents with Suppressed Immune Systems: A Prospective, Observational Study Save
- Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda Save
- Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial Save
- Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine Save
- Clinical profile of paediatric acute rheumatic fever and rheumatic heart disease in Western Australia: 1987 to 2020 Save
- Effects of Two Early Parenting Programmes on Child Aggression and Risk for Violence in Brazil: a Randomised Controlled Trial Save
- Safety and Immunogenicity of an Acellular Pertussis Vaccine Containing Genetically-Detoxified Pertussis Toxin Administered to Pregnant Women Living with and Without HIV and Their New-Borns: A Randomised Controlled Trial in Uganda Save
- Sex- and Age-Specific Differences in Risk Profiles and Early Outcomes in Adults With Acute Coronary Syndromes Save
- Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): Study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi … Save
- Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study – A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines Save
- Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18–50 Years and RSV-Seropositive Children 12–24 Months Save
- Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial Save
- The PHOENIX RCT Planned delivery for pre-eclampsia between 34 and 37 weeks of gestation: the PHOENIX RCT Save
- Cost-Utility Analysis of Planned Early Delivery or Expectant Management for Late Preterm Pre-eclampsia (PHOENIX) Save
- Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial Save
- Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial Save
- Long-term trends in population-based hospitalisation rates for myocardial infarction in England: A national database study of 3.5 million admissions, 1968-2016 Save
- Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS Save